Vanish

product on market Capsule PS ProSupps Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Vanish
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
8 mg (2% DV)
Fat Burning Matrix
253 mg
Euphoric Matrix
78 mg
Appetite Control Matrix
34 mg

Other Ingredients

Hypromellose Silica Magnesium Stearate Maltodextrin Candurin Silver Fine Carmine
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

SUGGESTED USE: AS A DIETARY SUPPLEMENT, TAKE 1 CAPSULE PER SERVING.

Warnings & Precautions

CONSULT WITH YOUR PHYSICIAN PRIOR TO USE IF YOU ARE PREGNANT OR NURSING, OR IF YOU ARE TAKING MEDICATION, INCLUDING BUT NOT LIMITED TO MAOI’S, ANTIDEPRESSANTS, ASPRIN, NON STEROIDAL ANTI-INFLAMMATORY DRUGS OR PRODUCTS CONTAINING PHYLEPHRINE, EPHEDRINE, PSEUDOEPHEDRINE, OR OTHER STIMULANTS.

CONSULT YOUR PHYSICIAN PRIOR TO USE IF YOU HAVE A MEDICAL CONDITION, INCLUDING BUT NOT LIMITED TO, HEART, LIVER, KIDNEY, OR THYROID DISEASE, PYSCHIATRIC OR EPILEPTIC DISORDERS, DIFFICULTY URINATING, DIABETES, HIGH BLOOD PRESSURE, CARDIAC ARRHYTHMIA, RECURRENT HEADACHES, ENLARGED PROSTATE OR GLAUCOMA. DISCONTINUE 2 WEEKS PRIOR TO SURGERY OR IF YOU EXPERIENCE RAPID HEART BEAT, DIZZINESS, SEVERE HEADACHE OR SHORTNESS OF BREATH.

HUPERZINE WARNING: CONSULT WITH YOUR PHYSICIAN PRIOR TO USE IF YOU ARE PREGNANT OR NURSING, HAVE HIGH BLOOD PRESSURE OR HEART PROBLEMS, OR ARE TAKING PRESCRIPTION DRUGS.

DO NOT EXCEED 4 CAPSULES PER DAY. CONSULT WITH YOUR PHYSICIAN PRIOR TO USING THIS PRODUCT.

SYNEPHRINE WARNING: DO NOT CONSUME SYNEPHRINE OR CAFFEINE FROM OTHER SOURCES, INCLUDING BUT NOT LIMITED TO, COFFEE, TEA, SODA AND OTHER DIETARY SUPPLEMENTS OR MEDICATIONS CONTAINING PHENYLEPHRINE OR CAFFEINE. CONTAINS CAFFEINE.

DO NOT USE FOR MORE THAN 8 WEEKS.

Formulation Notes

CONTAINS CAFFEINE.

Additional Information

prosupps(R) RESULTS . . . PERIOD!+

Ps(R)

>>> FAT METABOLIZER+

> ENHANCES MOOD AND MENTAL CLARITY + > SUPPRESSES APPETITE AND CRAVINGS + > PROMOTES FAT LOSS +

US

GLUTEN FREE

MADE IN USA

Metadata

Product Details

UPC / SKU7 00443 66604 6
DSLD Entry Date2015-07-24
Product TypeOther Combinations
FormCapsule
DSLD ID47897
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.